The Specialty Pharmacy Review Board™ — Examining Emerging Biologics for Difficult-to-treat or Severe Asthma
Reserve your spot today for a Satellite Dinner Symposium
The Specialty Pharmacy Review Board™ — Examining Emerging Biologics for Difficult-to-treat or Severe Asthma

Jointly provided by Impact Education, LLC and Postgraduate Institute for Medicine.
Impact Education, LLC     Postgraduate Institute for Medicine
This activity is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Monday, October 22, 2018
6:00 PM - 8:00 PM
Orlando World Marriott Center
Room: Canary 1-2
Orlando, FL


Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2018 is required.
Held in conjunction with

  Review Board Topics Include:
  • New and emerging biologic therapies for difficult-to-treat or severe asthma
  • Techniques to assess asthma severity and symptom control
  • Cost implications of treating difficult-to-treat or severe asthma
  • Care management strategies to improve the coordination of care for patients with difficult-to-treat or severe asthma
  Expert Faculty Presenters
Jeffrey Dunn, PharmD, MBA
Vice President, Clinical Strategy and Programs and Industry Relations
Magellan Rx Management
Edmund Pezalla, MD, MPH
CEO
Enlightenment Bioconsult, LLC
Steven G. Avey, MS, RPh, FAMCP
Vice President
Specialty Pharmacy Programs
MedImpact Healthcare Systems, Inc.
Michael Wechsler, MD
Professor of Medicine
Director, NJH Cohen Family Asthma Institute
Department of Medicine
National Jewish Health
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP Nexus 2018 Meeting.

  Statement of Need/Program Overview

This symposium will feature a multidisciplinary faculty panel who will present best practices for implementing collaborative treatment and patient management decisions that lead to optimal outcomes for patients with severe asthma. This approach will enhance the audiences' ability to recommend and implement payer specific techniques to improve the continuity of care related to the impact of asthma management strategies on clinical outcomes, value, and economic consequences for the entire health care system. The Specialty Pharmacy Review Board™ format will be similar to a mock pharmacy and therapeutics committee meeting, featuring an expert panel including a leading asthma specialist, a specialty pharmacy director, and managed care medical and pharmacy directors.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Discuss the current management of difficult-to-treat or severe asthma, including guideline recommendations and new and emerging treatments
  • Explore techniques to assess asthma severity and symptom control
  • Examine the implications for managed care of treating difficult-to-treat or severe asthma, including medical costs and resource utilization
  • Employ care planning strategies to increase the delivery of coordinated, multidisciplinary care for patients with difficult-to-treat or severe asthma
  Agenda

Date and Time
Monday, October 22, 2018
6:00 PM - 8:00 PM
Orlando World Center Marriott
Room: Canary 1-2
Orlando, FL

6:00 PM Dinner and Registration
Pre-Activity Learning Assessment and Opening Comments/Overview
6:05 PM Assessing the Clinical Benefits and Appropriate Use of Biologics for Difficult-to-treat or Severe Asthma
Michael Wechsler, MD
6:35 PM Integrating Emerging Biologic Therapies into Health Plan Asthma Treatment Algorithms
Edmund Pezalla, MD, MPH
7:00 PM Faculty Idea Exchange
7:05 PM Medical and Pharmacy Benefit Design Strategies for Biologic Therapies
Jeffrey Dunn, PharmD, MBA
7:25 PM Care Coordination Strategies to Enhance Patient Outcomes with Difficult-to-treat or Server Asthma
Steven G. Avey, MS, RPh, FAMCP
7:45 PM Moderated Faculty Panel Discussion and Audience Q&A
Entire Faculty Panel
8:00 PM Closing Comments; Post-Activity Assessment and Evaluations

  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-18-348-L01-P
Type of Activity: Application

Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2018 is required.

Pre-registration will close at 12:00 pm on October 21, 2018.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.